Tenet Healthcare CORP Form 4 insider transactions

Meghan Fitzgerald, a Director at Tenet Healthcare Corp (THC), reported transactions involving restricted stock units and common stock.

Vineeta Agarwala, a Director at Tenet Healthcare Corp, acquired 1,333 shares of common stock on May 22, 2026, through restricted stock units.

Tenet Healthcare Corp. director Cecil D. Haney reported transactions involving restricted stock units and common stock.

Director Richard J. Mark reported transactions involving Tenet Healthcare Corp. common stock and restricted stock units.

J. Robert Kerrey, a Director at Tenet Healthcare Corp (THC), reported transactions involving common stock and restricted stock units.

Director Roy Blunt of Tenet Healthcare Corp. reported transactions involving restricted stock units and common stock.

Tenet Healthcare's EVP and Chief Information Officer, Paola M. Arbour, reported the sale of 6,500 shares of common stock.

Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside new RSU grants.

Tenet Healthcare's EVP & CFO, Sun Park, reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside a new RSU grant.

Tenet Healthcare's EVP, Chief Information Officer, Paola M. Arbour, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Tenet Healthcare's EVP and Chief Operating Officer, Lisa Y. Foo, reported the vesting of restricted stock units and subsequent tax-related share dispositions.

Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, reported the sale of all his directly held common stock following RSU vesting.

Thomas W. Arnst, EVP, Chief Admin. Officer & GC of Tenet Healthcare Corp, reported significant stock transactions including RSU vesting, tax-related dispositions, and a substantial sale of common stock.

Tenet Healthcare's EVP & Chief Financial Officer, Sun Park, converted 3,800 restricted stock units into common stock on February 24, 2026.

Tenet Healthcare CEO Saumya Sutaria converted 18,242 restricted stock units into common stock as part of a scheduled vesting event.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp., acquired 1,267 shares of common stock through the vesting of restricted stock units.

Tenet Healthcare's EVP and Chief Operating Officer, Lisa Y. Foo, acquired 3,800 shares of common stock through the vesting of restricted stock units.

Tenet Healthcare's EVP, Chief Administrative Officer & General Counsel, Thomas W. Arnst, acquired 3,800 shares of common stock through the vesting of restricted stock units.

Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, converted 443 restricted stock units into common stock following the vesting of the first increment.

Tenet Healthcare Corp. Director Nadja West reported a planned donation of 1,515 common shares to a charitable donor advised fund.

Tenet Healthcare CEO Saumya Sutaria reported the vesting of restricted stock units and subsequent tax-related share disposition on December 31, 2025.

Tenet Healthcare Corp. Director Nadja West sold 2,178 shares of common stock at a weighted average price of $197.47.

Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, sold all 13,322 beneficially owned shares of common stock on November 6, 2025, under a pre-arranged trading plan.

Tenet Healthcare Director Tammy Romo sold 645 shares of common stock at $205.2 per share on November 5, 2025.

A director at Tenet Healthcare Corp. sold over 26,000 shares of common stock for approximately $5.4 million under a pre-arranged trading plan.

Tenet Healthcare Corp. Director Richard W. Fisher sold 2,500 shares of common stock for approximately $521,075 on October 29, 2025.

Tenet Healthcare Corp Director J. Robert Kerrey reported a charitable contribution of 971 common shares.

Tenet Healthcare CEO Saumya Sutaria sold 78,762 shares of common stock for approximately $15 million in two pre-arranged transactions on September 10, 2025.

Tenet Healthcare CEO Saumya Sutaria converted restricted stock units into common stock and subsequently sold shares to cover tax obligations.

Tenet Healthcare Director Christopher S. Lynch reported the sale of 8 shares of common stock for $183.44 per share, executed under a Rule 10b5-1 plan.